<?xml encoding="utf-8" ?> Axogen Inc. AXGN on Thursday agreed to acquire a privately held medical device manufacturer, ...

Acquisition adds NerveTape™, the 1st FDA-approved device for sutureless peripheral nerve repair, broadening Axogen’s addressable market within its focus markets Axogen’s commercial infrastructure, ...

The US Food and Drug Administration (FDA) has granted de novo marketing authorisation to TISSIUM's COAPTIUM CONNECT, representing the first atraumatic option for repairing peripheral nerve damage.

Veronica Paulus is a former STAT intern supported by the Harvard University Institute of Politics. A sutureless device for peripheral nerve repair could be available on the market in the coming months ...

Tissium has raised €60M to carry the world’s only FDA-cleared sutureless nerve repair system into US operating rooms. The Paris medtech wants to swap the surgeon’s needle for a dab of light-cured glue ...